Yabing Nan

450 total citations
10 papers, 241 citations indexed

About

Yabing Nan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yabing Nan has authored 10 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Yabing Nan's work include RNA modifications and cancer (5 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer-related molecular mechanisms research (3 papers). Yabing Nan is often cited by papers focused on RNA modifications and cancer (5 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer-related molecular mechanisms research (3 papers). Yabing Nan collaborates with scholars based in China and United States. Yabing Nan's co-authors include Zhihua Liu, Pengfei Zhao, Xiaowei Wu, Qingyu Luo, Wan Chang, Dan Su, Xiaolin Zhu, Yiping Zhang, Jonathan P. Katz and Lingqiang Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Oncogene.

In The Last Decade

Yabing Nan

10 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yabing Nan China 9 201 78 60 30 25 10 241
Hongbo Su China 11 201 1.0× 115 1.5× 55 0.9× 41 1.4× 22 0.9× 22 281
Zelong Lin China 8 163 0.8× 106 1.4× 63 1.1× 39 1.3× 18 0.7× 13 268
Chunmei Kuang China 7 205 1.0× 78 1.0× 81 1.4× 19 0.6× 23 0.9× 15 284
Xuebing Jia China 12 195 1.0× 121 1.6× 58 1.0× 51 1.7× 34 1.4× 17 293
Jiansheng Guo China 10 150 0.7× 127 1.6× 57 0.9× 27 0.9× 17 0.7× 19 251
Mingdian Lu China 9 198 1.0× 101 1.3× 45 0.8× 26 0.9× 20 0.8× 15 271
Purificación Estévez-García Spain 8 183 0.9× 121 1.6× 78 1.3× 21 0.7× 24 1.0× 19 272
Oksana Mashadova United States 4 175 0.9× 105 1.3× 86 1.4× 16 0.5× 12 0.5× 5 252
Mathilde Savall France 5 178 0.9× 126 1.6× 40 0.7× 17 0.6× 22 0.9× 5 261
Shoumei Yang China 6 225 1.1× 172 2.2× 48 0.8× 17 0.6× 17 0.7× 8 296

Countries citing papers authored by Yabing Nan

Since Specialization
Citations

This map shows the geographic impact of Yabing Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yabing Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yabing Nan more than expected).

Fields of papers citing papers by Yabing Nan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yabing Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yabing Nan. The network helps show where Yabing Nan may publish in the future.

Co-authorship network of co-authors of Yabing Nan

This figure shows the co-authorship network connecting the top 25 collaborators of Yabing Nan. A scholar is included among the top collaborators of Yabing Nan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yabing Nan. Yabing Nan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Nan, Yabing, Xiaowei Wu, Qingyu Luo, et al.. (2024). OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition. Proceedings of the National Academy of Sciences. 121(19). e2315348121–e2315348121. 12 indexed citations
2.
Nan, Yabing, Qingyu Luo, Xiaowei Wu, et al.. (2023). m6A demethylase FTO stabilizes LINK-A to exert oncogenic roles via MCM3-mediated cell-cycle progression and HIF-1α activation. Cell Reports. 42(10). 113273–113273. 15 indexed citations
3.
Zhao, Pengfei, Qingyu Luo, Xiaowei Wu, et al.. (2023). RUNX1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression. Oncogene. 43(6). 420–433. 9 indexed citations
4.
Zhao, Pengfei, Yating Wang, Yu Xiao, et al.. (2023). Long noncoding RNA LOC646029 functions as a ceRNA to suppress ovarian cancer progression through the miR-627-3p/SPRED1 axis. Frontiers of Medicine. 17(5). 924–938. 5 indexed citations
5.
Nan, Yabing, Qingyu Luo, Xiaowei Wu, et al.. (2022). HCP5 prevents ubiquitination-mediated UTP3 degradation to inhibit apoptosis by activating c-Myc transcriptional activity. Molecular Therapy. 31(2). 552–568. 23 indexed citations
6.
Nan, Yabing, Qingyu Luo, Xiaowei Wu, et al.. (2022). DLGAP1-AS2–Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma. Cancer Research. 82(16). 2887–2903. 19 indexed citations
7.
Chang, Wan, Qingyu Luo, Xiaowei Wu, et al.. (2022). OTUB2 exerts tumor-suppressive roles via STAT1-mediated CALML3 activation and increased phosphatidylserine synthesis. Cell Reports. 41(4). 111561–111561. 28 indexed citations
8.
Luo, Qingyu, Xiaowei Wu, Pengfei Zhao, et al.. (2021). OTUD1 Activates Caspase‐Independent and Caspase‐Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation. Advanced Science. 8(8). 2002874–2002874. 55 indexed citations
9.
Luo, Qingyu, Xiaowei Wu, Yabing Nan, et al.. (2020). TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma. Cell Reports. 30(1). 98–111.e5. 40 indexed citations
10.
Luo, Qingyu, Xiaowei Wu, Wan Chang, et al.. (2019). ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness. Cell Death and Differentiation. 27(6). 1981–1997. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongbo Su Breakdown of academic impact, for papers by Zelong Lin Breakdown of academic impact, for papers by Chunmei Kuang Breakdown of academic impact, for papers by Xuebing Jia Breakdown of academic impact, for papers by Jiansheng Guo Breakdown of academic impact, for papers by Mingdian Lu Breakdown of academic impact, for papers by Purificación Estévez-García Breakdown of academic impact, for papers by Oksana Mashadova Breakdown of academic impact, for papers by Mathilde Savall Breakdown of academic impact, for papers by Shoumei Yang
Rankless by CCL
2026